Marshall Islands Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Marshall Islands Tech Journal.

Press releases published on June 23, 2026

2 hours ago

Attention Raises $30M Series B to Build the AI System That Runs Revenue Teams — Not Just Records Them

Indeterminate GlobeNewswire

3 hours ago

De werkelijke kosten van cyberdowntime: een briefing op bestuursniveau in Nederland

Indeterminate GlobeNewswire

3 hours ago

WEMADE to Launch RAVN Season 4 for NIGHT CROWS on June 30

Indeterminate GlobeNewswire

3 hours ago

Mehr Sicherheit, weniger Sorgen – genießen Sie diesen Prime Day: EZVIZ bietet unwiderstehliche Angebote für bewährte Smart-Home-Lösungen für mehr Sicherheit im Alltag

Indeterminate GlobeNewswire

3 hours ago

Enjoy more security, less worry this Prime Day: EZVIZ rolls out irresistible deals on trusted smart home solutions for greater everyday confidence

Indeterminate GlobeNewswire

3 hours ago

Profitez de plus de sécurité et de moins d’inquiétudes pendant ce Prime Day: EZVIZ lance des offres irrésistibles sur des solutions de maison intelligente fiables pour plus de sérénité au quotidien

Indeterminate GlobeNewswire

3 hours ago

Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

Indeterminate GlobeNewswire

3 hours ago

Menroc Asset Management Sees Growing Preference for Income-Focused Investments

Indeterminate GlobeNewswire

5 hours ago

Syncron Appoints Bianka Hay-Falk as Chief Human Resources Officer

Indeterminate GlobeNewswire

6 hours ago

Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia

Indeterminate GlobeNewswire

6 hours ago

Communiqué de presse : Wayrilz de Sanofi a été approuvé au Japon pour traiter la thrombocytopénie immunitaire

Indeterminate GlobeNewswire

6 hours ago

Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses

Indeterminate GlobeNewswire

6 hours ago

Communiqué de presse : Cenrifki (tolebrutinib) de Sanofi approuvé dans l’UE comme premier médicament ciblant la progression du handicap dans la sclérose en plaques secondairement progressive sans rechutes

Indeterminate GlobeNewswire

6 hours ago

argenx to Host Autoimmune Myositis R&D Webinar

Indeterminate GlobeNewswire

10 hours ago

Crypto News Today: AlphaPepe Nears Third CEX Partnership as Ethereum Price Prediction Targets $7,000

Indeterminate GlobeNewswire

10 hours ago

Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

11 hours ago

COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment

Indeterminate GlobeNewswire

11 hours ago

Shenzhen HQVT Technology Lists on HKEX Main Board, Accelerating Implementation of Multispectral AI Technology

Indeterminate GlobeNewswire